Privia Health Group, Inc. (NASDAQ:PRVA) Stock Position Reduced by Vanguard Group Inc.

Vanguard Group Inc. lessened its position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 3.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,421,710 shares of the company's stock after selling 419,169 shares during the period. Vanguard Group Inc. owned approximately 9.52% of Privia Health Group worth $223,294,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Riverbridge Partners LLC increased its stake in shares of Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after purchasing an additional 958,418 shares during the period. Geode Capital Management LLC increased its position in Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after acquiring an additional 23,178 shares during the period. Franklin Resources Inc. raised its stake in Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after acquiring an additional 28,480 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Privia Health Group by 6.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company's stock worth $22,167,000 after acquiring an additional 69,649 shares during the period. Finally, Sei Investments Co. boosted its position in Privia Health Group by 26.2% during the 4th quarter. Sei Investments Co. now owns 573,635 shares of the company's stock worth $11,215,000 after acquiring an additional 119,052 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Needham & Company LLC restated a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a research note on Thursday. Stephens reaffirmed an "overweight" rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Truist Financial increased their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a report on Thursday. Macquarie began coverage on Privia Health Group in a report on Monday, December 16th. They set an "outperform" rating and a $25.00 target price on the stock. Finally, JMP Securities set a $29.00 price target on Privia Health Group in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $26.87.

Privia Health Group Stock Performance

PRVA traded up $0.60 during trading on Thursday, reaching $23.65. The company had a trading volume of 1,030,395 shares, compared to its average volume of 787,626. The firm's 50-day simple moving average is $23.74 and its 200 day simple moving average is $21.44. The company has a market cap of $2.87 billion, a price-to-earnings ratio of 236.52, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04.

Insiders Place Their Bets

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the sale, the chief financial officer now directly owns 179,676 shares of the company's stock, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 14.20% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.